Jpmorgan Chase & CO Bausch Health Companies Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,474 shares of BHC stock, worth $14,283. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,474

Previous 62,631 97.65%

Holding current value

$14,283

Previous $664,000 98.49%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$6.1 - $10.41 $373,057 - $636,644	-61,157 Reduced 97.65%	1,474 $10,000
Q1 2024 May 10, 2024	SELL	$7.77 - $10.61 $1.76 Million - $2.41 Million	-226,838 Reduced 78.36%	62,631 $664,000
Q4 2023 Feb 12, 2024	BUY	$6.53 - $8.23 $1.54 Million - $1.94 Million	236,158 Added 442.98%	289,469 $2.32 Million
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $1,538 - $1,942	-200 Reduced 0.37%	53,311 $438,000
Q2 2023 Aug 11, 2023	BUY	$5.72 - $8.8 $12,812 - $19,712	2,240 Added 4.37%	53,511 $428,000
Q1 2023 May 11, 2023	BUY	$6.28 - $9.85 $34,062 - $53,426	5,424 Added 11.83%	51,271 $415,000
Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $5.89 Million - $7.66 Million	-966,385 Reduced 95.47%	45,847 $288,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $8.63 Million - $17.4 Million	-1,884,957 Reduced 65.06%	1,012,232 $6.97 Million
Q2 2022 Aug 11, 2022	BUY	$7.06 - $23.63 $8.37 Million - $28 Million	1,185,543 Added 69.26%	2,897,189 $24.2 Million
Q1 2022 May 11, 2022	BUY	$21.6 - $27.79 $16,156 - $20,786	748 Added 0.04%	1,711,646 $39.1 Million
Q4 2021 Feb 10, 2022	BUY	$23.0 - $29.01 $2.01 Million - $2.53 Million	87,191 Added 5.37%	1,710,898 $47.2 Million
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $40.7 Million - $48.8 Million	1,623,707 New	1,623,707 $45.2 Million

Others Institutions Holding BHC

# of Institutions

265

Shares Held

279M

Call Options Held

5.68M

Put Options Held

17.4M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.51B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Bausch Health Companies Inc. Transaction History